Alberta Investment Management Corp (AIMCo)’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-89,900
Closed -$342K 878
2016
Q4
$342K Buy
+89,900
New +$653K ﹤0.01% 642
2016
Q3
Sell
-99,100
Closed -$697K 772
2016
Q2
$697K Buy
+99,100
New +$905K 0.01% 534

Other funds holding PACB

Alberta Investment Management Corp (AIMCo)'s PACB Position: Q1 2017 in Review

Alberta Investment Management Corp (AIMCo) sold out of Pacific Biosciences (PACB) in Q1 2017, closing a stake of 89,900 shares — an estimated $342K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in PACB in Q2 2016 and held it in 2 quarters. The position peaked at $697K in Q2 2016. 106 funds tracked by Wall St. Rank hold PACB as of Q1 2017.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Pacific Biosciences position as of Q1 2017 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 89,900 Pacific Biosciences shares in Q1 2017, an estimated $342K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Pacific Biosciences in Q2 2016 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Pacific Biosciences position peaked at $697K in Q2 2016.
  • 106 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2017.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2017, filed 15 May 2017.